Hematologic Oncology Update

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:
Introduction (0:00)
Prologue: Saturday Night Fever (1:35)
Baby Boomers' Guide to Mechanisms of Action (3:07)
Second-Line Treatment (12:36)
Complications Associated with Bispecific Antibodies (23:41)
Case Presentations (25:52)
New Bispecific T-Cell Engagers — Surovatamig (26:24)
Other Novel Agents (50:05)

CME information and select publications

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:
Multiple Myeloma (0:00)
Introduction: ESMO 2026; Recent FDA Approvals (1:53)
Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
Bispecific Antibodies — Dr Lonial (19:16)
Antibody-Drug Conjugates — Dr Richardson (37:08)
Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

CME information and select publications

Featuring an interview with Dr Matthew Lunning, including the following topics:
Bispecific antibody/antibody-drug conjugate combinations (0:00)
A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

CME information and select publications

Featuring a presentation by Dr Matthew Matasar, including the following topics:
Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
Discussion of Questions from the Community (50:20)

CME information and select publications

Featuring an interview with Dr Matthew Lunning, including the following topics:
A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann LaCasce, MD, MMSc (0:00)
CNS prophylaxis in non-Hodgkin lymphoma (7:58)

CME information and select publications